NCT03967483

Brief Summary

Description of modalities concerning the patient care of headaches sensible to indometacine.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2019

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 30, 2019

Completed
2 days until next milestone

Study Start

First participant enrolled

June 1, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

May 30, 2019

Status Verified

May 1, 2019

Enrollment Period

1 year

First QC Date

May 27, 2019

Last Update Submit

May 27, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Description of headaches sensible to indometacine

    Description of the clinical cases with headaches sensible to indometacine according to the type of headaches.

    24 monthes

Interventions

patient who are taken indomatacin for headaches and migraine

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient sufffuring from headaches or migraine and who is receiving Indometacine

You may qualify if:

  • patient with a diagnosis of migraine with or without aura, or trigemino-autosomic headaches or other primary headaches
  • patient who are taking indometacine
  • patient with written consent form

You may not qualify if:

  • patient under 18 years
  • pregnant woman or breastfeeding patient
  • patient who refuses to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Migraine Disorders

Interventions

Indomethacin

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

IndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Pr

Study Record Dates

First Submitted

May 27, 2019

First Posted

May 30, 2019

Study Start

June 1, 2019

Primary Completion

June 1, 2020

Study Completion

June 1, 2021

Last Updated

May 30, 2019

Record last verified: 2019-05